Classen Immunotherapies, Inc. v. Biogen Idec

United States Court of Appeals for the Federal Circuit ______________________ September 12, 2011 ERRATA ______________________ 2006-1634, -1649 CLASSEN IMMUNOTHERAPIES, INC., Plaintiff-Appellant, v. BIOGEN IDEC, Defendant-Appellee, and GLAXOSMITHKLINE, Defendant-Appellee, and MERCK & CO., INC., Defendant-Cross Appellant, and CHIRON CORPORATION, KAISER-PERMANENTE, INC., KAISER PERMANENTE VENTURES, KAISER PERMANENTE INTERNATIONAL, KAISER PERMANENTE INSURANCE COMPANY, THE PERMANENTE FEDERATION, LLC, THE PERMANENTE COMPANY, LLC, THE PERMANENTE FOUNDATION, THE PERMANENTE MEDICAL GROUP, INC., KAISER FOUNDATION HOSPITALS, KAISER FOUNDATION ADDED CHOICE HEALTH PLAN, INC., and KAISER FOUNDATION HEALTH PLAN INC., Defendants. ______________________ Decided August 31, 2011 Precedential Opinion ______________________ Please make the following change: Page 2, the following corrections Donald R. Ware, Foley Hoag LLP, of Boston, Massachu- setts, for defendant-appellee, Biogen IDEC. With him on the brief were Barbara A. Fiacco and Jeremy A. Younkin. Of counsel were Joshua M. Hiller, Wilmer Cutler Pickering Hale and Dorr LLP, of Boston, Massachusetts, and David A. Wilson, of Washington, DC.